Lisa Watkinson

924 total citations
28 papers, 517 citations indexed

About

Lisa Watkinson is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Lisa Watkinson has authored 28 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Lisa Watkinson's work include Radiopharmaceutical Chemistry and Applications (14 papers), Peptidase Inhibition and Analysis (6 papers) and Receptor Mechanisms and Signaling (6 papers). Lisa Watkinson is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (14 papers), Peptidase Inhibition and Analysis (6 papers) and Receptor Mechanisms and Signaling (6 papers). Lisa Watkinson collaborates with scholars based in United States, Greece and Brazil. Lisa Watkinson's co-authors include Terry Carmack, John R. Lever, Charles J. Smith, Kattesh V. Katti, Silvia S. Jurisson, Susan Z. Lever, Timothy J. Hoffman, Cathy Cutler, Michael F. Giblin and Raghuraman Kannan and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Lisa Watkinson

25 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisa Watkinson United States	12	179	168	113	95	92	28	517
Terry Carmack United States	11	149 0.8×	149 0.9×	105 0.9×	85 0.9×	91 1.0×	24	486
Philippe Levêque Belgium	11	148 0.8×	124 0.7×	62 0.5×	67 0.7×	89 1.0×	15	365
Wenjiang Yang China	14	219 1.2×	132 0.8×	123 1.1×	68 0.7×	193 2.1×	45	603
Haiqing Zhong China	16	76 0.4×	161 1.0×	35 0.3×	39 0.4×	81 0.9×	33	658
Theodoros Tsotakos Greece	11	212 1.2×	92 0.5×	174 1.5×	75 0.8×	136 1.5×	19	516
Wendy Graham United States	12	273 1.5×	184 1.1×	73 0.6×	73 0.8×	73 0.8×	13	662
Duanzhi Yin China	11	127 0.7×	74 0.4×	97 0.9×	39 0.4×	83 0.9×	29	362
Ken Kersemans Belgium	15	215 1.2×	169 1.0×	66 0.6×	135 1.4×	78 0.8×	48	600
Lídia M. Andrade Brazil	15	30 0.2×	265 1.6×	54 0.5×	29 0.3×	148 1.6×	39	622
Célia Fernandes Portugal	16	345 1.9×	191 1.1×	47 0.4×	112 1.2×	44 0.5×	53	688

Countries citing papers authored by Lisa Watkinson

Since Specialization

Citations

This map shows the geographic impact of Lisa Watkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Watkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Watkinson more than expected).

Fields of papers citing papers by Lisa Watkinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Watkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Watkinson. The network helps show where Lisa Watkinson may publish in the future.

Co-authorship network of co-authors of Lisa Watkinson

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Watkinson. A scholar is included among the top collaborators of Lisa Watkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Watkinson. Lisa Watkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Longbo, Fabio Gallazzi, Lisa Watkinson, et al.. (2025). Effect of Click Chemistry Linkages on the Biological Behavior of Albumin-Binding ¹⁷⁷Lu-DOTAGA-pIBA-LLP2A Analogues Targeting Melanoma. Bioconjugate Chemistry. 36(9). 2002–2012. 1 indexed citations

Sakr, Tamer M., Velaphi C. Thipe, Kavita Katti, et al.. (2025). Immunomodulatory green nanomedicine production, tumor cellular targeting, in vivo biodistributions and preclinical therapeutic efficacy investigations of resveratrol-functionalized gold and theranostic ¹⁹⁸gold nanoparticles. Journal of Materials Chemistry B. 13(27). 8038–8050.

Lewis, Michael R., Maryam Heidari‐Kharaji, Vivian C. Yang, et al.. (2025). PET imaging of [64Cu]copper(II) chloride and tetrathiomolybdate administration in animal models of triple-negative breast cancer. Nuclear Medicine and Biology. 152-153. 109596–109596.

Tatum, David S., Lisa Watkinson, Terry Carmack, et al.. (2024). Single Chelator–Minibody Theranostic Agents for⁸⁹Zr PET Imaging and¹⁷⁷Lu Radiopharmaceutical Therapy of PSMA-Expressing Prostate Cancer. Journal of Nuclear Medicine. 65(9). 1435–1442. 2 indexed citations

Gallazzi, Fabio, et al.. (2024). Albumin-Binding Lutetium-177-Labeled LLP2A Derivatives as Theranostics for Melanoma. Molecular Pharmaceutics. 21(6). 2960–2969. 7 indexed citations

Lewis, Michael R., Mojgan Golzy, Anupam Mathur, et al.. (2024). Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen. Nuclear Medicine and Biology. 136-137. 108938–108938. 3 indexed citations

Higashi, Yusuke, Laurel A. Grisanti, Lisa Watkinson, et al.. (2023). Synthesis and preclinical evaluation of a novel fluorine-18 labeled small-molecule PET radiotracer for imaging of CXCR3 receptor in mouse models of atherosclerosis. EJNMMI Research. 13(1). 67–67. 3 indexed citations

Tatum, David S., Lisa Watkinson, Terry Carmack, et al.. (2023). Comparison of 89Zr-Lumi804-IAB2MA and 89Zr-DFO-IAB2MA for PSMA-targeted PET Imaging of Prostate Cancer. Nuclear Medicine and Biology. 126-127. 108732–108732.

Ma, Li, Cameron Grant, Fabio Gallazzi, et al.. (2022). Development and biodistribution studies of 77As-labeled trithiol RM2 bioconjugates for prostate cancer: Comparison of [77As]As-trithiol-Ser-Ser-RM2 vs. [77As]As-trithiol-Glu-Ser-RM2. Nuclear Medicine and Biology. 108-109. 61–69. 4 indexed citations

10.

Lever, John R., et al.. (2019). Design, synthesis and evaluation of 111In labeled DOTA-conjugated tetrapeptides having high affinity and selectivity for mu opioid receptors. Nuclear Medicine and Biology. 70. 53–66. 5 indexed citations

11.

Papagiannopoulou, Dionysia, Fabio Gallazzi, Lisa Watkinson, et al.. (2018). Synthesis and evaluation of Re/99mTc(I) complexes bearing a somatostatin receptor-targeting antagonist and labeled via a novel [N,S,O] clickable bifunctional chelating agent. Bioorganic & Medicinal Chemistry. 27(3). 492–501. 11 indexed citations

12.

Gallazzi, Fabio, Lisa Watkinson, Terry Carmack, et al.. (2016). Synthesis and evaluation of a 99mTc tricarbonyl-labeled somatostatin receptor-targeting antagonist peptide for imaging of neuroendocrine tumors. Nuclear Medicine and Biology. 47. 4–9. 18 indexed citations

13.

Lever, John R., et al.. (2014). Relationship between Cerebral Sigma-1 Receptor Occupancy and Attenuation of Cocaine’s Motor Stimulatory Effects in Mice by PD144418. Journal of Pharmacology and Experimental Therapeutics. 351(1). 153–163. 25 indexed citations

14.

Lever, John R., et al.. (2013). A selective sigma‐2 receptor ligand antagonizes cocaine‐induced hyperlocomotion in mice. Synapse. 68(2). 73–84. 25 indexed citations

15.

Lever, Susan Z., et al.. (2011). Synthesis, radioiodination and in vitro and in vivo sigma receptor studies of N-1-allyl-N´-4-phenethylpiperazine analogs. Nuclear Medicine and Biology. 39(3). 401–414. 14 indexed citations

16.

Cutler, Cathy, Para Kan, Nripen Chanda, et al.. (2010). Preparation and use of 198Au/199Au for potential applications in cancer therapy and imaging. Transactions of the American Nuclear Society. 103(1). 1123–1124. 2 indexed citations

17.

Figueroa, Said Daibes, Thomas P. Quinn, John R. Lever, et al.. (2009). Development of high-specific-activity 68Ga-labeled DOTA-rhenium-cyclized α-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors. Nuclear Medicine and Biology. 36(5). 505–513. 32 indexed citations

18.

Chanda, Nripen, Para Kan, Lisa Watkinson, et al.. (2009). Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor–bearing mice. Nanomedicine Nanotechnology Biology and Medicine. 6(2). 201–209. 183 indexed citations

19.

Liu, Dijie, Douglas M. Overbey, Lisa Watkinson, et al.. (2009). In vivo imaging of human colorectal cancer using radiolabeled analogs of the uroguanylin peptide hormone.. PubMed. 29(10). 3777–83. 16 indexed citations

20.

Quinn, Thomas P., John Lever, Timothy J. Hoffman, et al.. (2008). Development of high specific activity 68Ga-labeled DOTA-rhenium cyclized alpha-MSH peptide analog to target MC1 receptors over-expressed by melanoma tumors. Cancer Research. 68. 3165–3165. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact